Dejerine-Roussy syndrome
thalamic pain syndrome

More recently, research is being done in radiation therapy as long term treatment of Dejerine-Roussy syndrome.

Dejerine-Roussy syndrome is most commonly preceded by numbness in the affected side.

The name Dejerine-Roussy syndrome was coined after their deaths.

Although preliminary, these findings hold promise for an objective way to understand and treat patients with Dejerine-Roussy syndrome.

Many chemical medications have been used for a broad range of neuropathic pain including Dejerine-Roussy syndrome.

Dejerine-Roussy syndrome most often compromises tactile sensation.

Dejerine-Roussy syndrome: a syndrome caused by lesions of the posterior thalamus.

Anti-convulsants reduce neuronal hyperexcitability, effectively targeting Dejerine-Roussy syndrome.

They hypothesized that if cold water was streamed into the ear down the auditory canal, the symptoms associated with Dejerine-Roussy syndrome would be alleviated.

Of the millions experiencing strokes worldwide, over 30,000 in the United States alone have developed some form of Dejerine-Roussy syndrome.

The risk of developing Dejerine-Roussy syndrome is higher in older stroke patients, about 11% of stroke patients over the age of 80.

As initial stroke symptoms, numbness and tingling, dissipate, an imbalance in sensation causes these later syndromes, characterizing Dejerine-Roussy syndrome.

Dejerine-Roussy syndrome or thalamic pain syndrome is a condition developed after a thalamic stroke, a stroke causing damage to the thalamus.

Although debatable, these symptoms are rare and considered part of a "thalamic phenomenon", and are not normally considered a characteristic of Dejerine-Roussy syndrome.

Although there are many contributing factors and risks associated with strokes, there are very few associated with Dejerine-Roussy syndrome and thalamic lesions specifically.

It is now accepted that Dejerine-Roussy syndrome is a condition developed due to lesions interfering with the sensory process, which triggered the start of pharmaceutical and stimulation treatment research.

In 2007, Dr. V. S. Ramachandran and his lab proposed that caloric stimulation might be effective in treating Dejerine-Roussy syndrome.

Individuals with emerging Dejerine-Roussy syndrome usually report they are experiencing unusual pain or sensitivity that can be allodynic in nature or triggered by seemingly unrelated stimuli (sounds, tastes).

The imbalance in sensation characterized by Dejerine-Roussy syndrome can be argued through a model addressing a system of inputs and outputs that the brain must constantly process throughout life, suggesting latent plasticity.

Pain associated with Dejerine-Roussy syndrome is sometimes coupled with anosognosia or somatoparaphrenia which causes a patient having undergone a right-parietal, or right-sided stroke to deny any paralysis of the left side when indeed there is, or deny the paralyzed limb(s) belong to them.

Dejerine-Roussy syndrome has also been referred to as: "Posterior Thalamic Syndrome", "Retrolenticular Syndrome", "Thalamic Hyperesthetic Anesthesia", "Thalamic Pain Syndrome", "Thalamic Syndrome", "Central Pain Syndrome", and "Central Post-Stroke Syndrome".

She also developed thalamic pain syndrome, a special complication in stroke when the patient has suffered really severe brain trauma.

Dejerine-Roussy syndrome or thalamic pain syndrome is a condition developed after a thalamic stroke, a stroke causing damage to the thalamus.

The pain that accompanies it is severe and treated separately (the pain is similar to CRPS, phantom limb or thalamic pain syndrome).

Dejerine-Roussy syndrome has also been referred to as: "Posterior Thalamic Syndrome", "Retrolenticular Syndrome", "Thalamic Hyperesthetic Anesthesia", "Thalamic Pain Syndrome", "Thalamic Syndrome", "Central Pain Syndrome", and "Central Post-Stroke Syndrome".